Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.
about
Insulin in central nervous system: more than just a peripheral hormoneCardiovascular Risk Factors for Alzheimer's DiseaseAlzheimer's disease as homeostatic responses to age-related myelin breakdownMetabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersBlueberry supplementation improves memory in older adultsRosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III studyThe neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodiesRosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neuronsThe Rationale for Insulin Therapy in Alzheimer's DiseaseComplex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunctionMolecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalType 2 diabetes and cognitive impairment: linking mechanismsType 2 diabetes and cognitive impairment: contributions from neuroimagingInsulin: an emerging treatment for Alzheimer's disease dementia?Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the artLink between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatmentAlzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactionsEpidemiology of Alzheimer diseaseNew pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsInsulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's diseaseElevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brainInsulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndromeTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseTargeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunitiesRole of anti-diabetic drugs as therapeutic agents in Alzheimer's diseaseAlzheimer's disease and type 2 diabetes via chronic inflammatory mechanismsBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseProtection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomersThe ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated miceMechanisms underlying inflammation in neurodegenerationRosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status.Cognitive dysfunction and diabetes mellitusDicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesiaInfluence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's diseaseModulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma.Insulin, cognition, and dementiaEffects of insulin and octreotide on memory and growth hormone in Alzheimer's diseaseRepurposing diabetes drugs for brain insulin resistance in Alzheimer disease.Role of the adipose PPARγ-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors.Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.
P2860
Q21296648-B0A018E8-382B-49EB-B744-505453EC36AEQ22242643-770E781E-DDA0-43A9-8743-DD48F94FC5DDQ22251261-9F6742BF-9B0E-4E2E-8B59-47DF2C0A9A29Q24562763-3924B2F3-28C5-448E-AB53-20C511358557Q24602339-E73C6868-6B89-4D7C-9560-7572A039F3CBQ24628969-6F36DEE8-46AA-4008-B01D-3680695D2ABFQ24646616-6F63BE6A-85A6-4656-8839-EC5D420C4A35Q24652687-AA7A3255-5B59-4ACF-80B1-2781B7DB7C9DQ26744834-758D5AF8-2BDD-4F9F-A5DE-E18B7A721CBFQ26745936-CC1EAD58-60FC-4F9B-AB27-F1C95CDEE6C9Q26783344-6AE86FC0-CC76-4F97-A4E4-B1339B30E648Q26822993-66C1CD41-4250-4D98-805B-853619535F42Q26825253-AFC7F167-2924-449E-9A40-803F583F087CQ26827376-DE7D41AA-1B67-4C4B-BA62-A63B7FE6A894Q26830845-49CC2FD6-2C91-40FA-BADB-EB7E5C3C7C55Q26860246-E249E925-8EF9-445C-B2A3-F317AF7BD960Q26864965-5D015832-870D-4C5A-AFD4-8E4B31E0727CQ26865371-6786B4DB-A061-44DD-8DE2-4DB230168010Q26866006-6D6F9CB3-3386-4035-9F36-96F5AA65A1F7Q26866392-17CE167E-CC94-4DA1-BE0F-B4DA0B1AF472Q27003253-1DB96AB1-ABAB-437C-9288-FA65A098376CQ27008997-A1A454A8-20F1-485E-9B3D-96B1D36F221FQ27021700-38771DF9-32BD-47D7-AF3E-FCACB5F92B2CQ27338799-01049211-A0A8-4102-9BD5-4BA6071D53E7Q28083039-D6711200-40D0-4684-8726-E2067B3D9683Q28086892-06BFD1C1-4598-4EF2-8D88-182C8ED3A3FEQ28259585-52EF8C29-C139-4A42-9EB0-789B01B15796Q28308082-65836D2F-8B24-44DA-9B45-617F7F92EF92Q28742884-6C7DECCD-520B-40D0-AFC2-7EF6235CFF63Q29617977-D33DC1D8-F5F6-4BF2-97E0-C6C9AB0D68F6Q30471693-F4EA1F46-B3CA-49FC-A9C8-1B1F619B8986Q30489305-2249A68E-A41B-49A8-B8AD-0B4A7D627935Q33316237-5345A266-067E-4985-A094-B753462C5C0FQ33562308-37D75F6F-834D-44FC-A953-2C2B89FCEF98Q33575523-F51A7E1F-EBE0-444F-81FB-323C95FE1D4FQ33604874-C467A739-FED4-4515-BFCB-7DFA16060C15Q33742199-1211507A-5159-4BA4-AB80-301E55DB79C1Q33789329-70C4CFF1-251E-438E-AB80-B9EC1D9CB206Q33790412-7A8870F3-13C9-4663-A90E-52EED1824D84Q33800802-904EE096-0637-4978-BEB1-7875B4F0E7AF
P2860
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Preserved cognition in patient ...... litazone: a preliminary study.
@ast
Preserved cognition in patient ...... litazone: a preliminary study.
@en
Preserved cognition in patient ...... litazone: a preliminary study.
@nl
type
label
Preserved cognition in patient ...... litazone: a preliminary study.
@ast
Preserved cognition in patient ...... litazone: a preliminary study.
@en
Preserved cognition in patient ...... litazone: a preliminary study.
@nl
prefLabel
Preserved cognition in patient ...... litazone: a preliminary study.
@ast
Preserved cognition in patient ...... litazone: a preliminary study.
@en
Preserved cognition in patient ...... litazone: a preliminary study.
@nl
P2093
P1476
Preserved cognition in patient ...... litazone: a preliminary study.
@en
P2093
Brenna A Cholerton
David G Cook
G Stennis Watson
J Jacob Kulstad
Laura D Baker
Mark A Fishel
Mark A Reger
Michelle L Keeling
Pattie S Green
Sanjay Asthana
P304
P356
10.1176/APPI.AJGP.13.11.950
P577
2005-11-01T00:00:00Z